NCT06243978Active, not recruiting
Effectiveness of a Digital Health Application for Primary Hypertension (Liebria)
Effectiveness of a Digital Health Application for Primary Hypertension (Liebria): Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 16 Jun 2026
Brief summary (registry, in English)
This clinical trial with 328 patients with primary hypertension aims to investigate the effectiveness of the self-guided digital application liebria for patients with primary hypertension.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 328 (estimated)
- First submitted
- 17 Jan 2024
- Start date
- 2 Apr 2024
- Primary completion date
- Jun 2026
- Lead sponsor
- Gaia AG
- Diseases
- High blood pressure
- NCT number
- NCT06243978
What you commit to
- Study type: Interventional
- Planned participants: 328
- From 2 Apr 2024 to the primary completion date, Jun 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- \> Triple combination of antihypertensive medication
Other illness
- History of secondary hypertension (e.g., thyroid disease, kidney disease)
Other
- Home-based SBP \> 180 mmHg
- Pregnancy
Who the study is looking for
- Age ≥ 18
- Presence of primary hypertension, confirmed by submission of a medical certificate or equivalent (e.g., informal letter signed by primary care physician); relevant ICD-10-GM diagnoses:
- I10.00 (Benign essential hypertension: Without indication of hypertensive crisis)
- I10.90 (Essential hypertension, unspecified: Without indication of hypertensive crisis)
- Unmedicated or with existing antihypertensive drug therapy (with stable dose in the past 6 weeks prior to study enrolment)
- Last reported office-based systolic blood pressure (SBP) ≥ 140 mmHg followed by home-based SBP ≥ 135 mmHg
- Consent to participate
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| GAIA AG Coordinator of this site? Confirm its status | Hamburg | Germany | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.